Buse discusses the shortcomings of current CGM and AID technologies, as well as how current research aims to address them and further reduce hypoglycemia risk.
John Buse, M.D., Ph.D.
Advertisement
Articles by John Buse, M.D., Ph.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Ritlecitinib Stabilizes Vitiligo in Tranquillo Trial, With Iltefat Hamzavi, MD
2
Advances in Treating High-Impact Psoriasis from EADV 2026
3
The Benefits and Limits of Enlicitide, With Ninel Hovnanians, MD
4
6 Nephrology Headlines You Missed in September 2026
5